학술논문

Integrating bevacizumab, everolimus, and lapatinib into current neoadjuvant chemotherapy regimen for primary breast cancer. Safety results of the GeparQuinto trial
Document Type
Article
Source
In Annals of Oncology February 2011 22(2):301-306
Subject
Language
ISSN
0923-7534